Skip to content

Bausch + Lomb BLCO Debt Maturity - Thereafter

Debt Maturity - Thereafter at other companies

Solventum logo
SolventumSOLV
Viatris logo
ViatrisVTRS
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's debt maturity - thereafter.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's debt maturity - thereafter?
Bausch + Lomb (BLCO) reported debt maturity - thereafter of $0 in Q1 2026.
What does debt maturity - thereafter mean?
The aggregate principal amount of long-term debt scheduled to mature after the specified multi-year window. This represents the company's long-term debt burden and provides a view of the total debt tail. It is crucial for understanding the company's long-term leverage and capital structure sustainability.